The expanding indications for clozapine.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Experimental and clinical psychopharmacology

• Publication date

  1997-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1037/1064-1297.5.3.216PMID 9260069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Forschung

  2015cited by this paper
• Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia — a retrospective study of 387 patients

  2004cited by this paper
• Clozapine in the treatment of 121 out-patients

  2004cited by this paper
• Clozapine: neuroleptic-induced EPS and tardive dyskinesia

  2004cited by this paper
• Treatment of drug-induced exogenous psychosis in Parkinsonism with clozapine and fluperlapine

  2004cited by this paper
• Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

  2004cited by this paper
• Clozapine pharmacology and tardive dyskinesia

  2004cited by this paper
• Neuroleptic malignant syndrome.

  2000cited by this paper
• Management of the adverse effects of clozapine.

  1998cited by this paper
• Ciba Foundation Symposium

  1997cited by this paper
• Diagnosis and psychopharmacology of childhood and adolescent disorders

  1997cited by this paper
• Clinical effects of clozapine on autistic disorder.

  1996cited by this paper
• Schizophrenia and affective disorder--distinct entities or continuum?: an analysis based on a prospective 6-year follow-up.

  1996cited by this paper
• Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment.

  1996cited by this paper
• Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis.

  1996cited by this paper
• Clozapine for treatment-refractory mania.

  1996cited by this paper
• Clozapine in rapid cycling bipolar disorder.

  1996cited by this paper
• Clozapine treatment in polydipsia and intermittent hyponatremia.

  1996cited by this paper
• Opposite Modulation of Cocaine-Seeking Behavior by D1- and D2-Like Dopamine Receptor Agonists

  1996cited by this paper
• Serotonin-dopamine interaction and its relevance to schizophrenia.

  1996cited by this paper
• Clozapine treatment in polydipsia and intermittent hyponatremia

  1996cited by this paper
• Cost-effectiveness of clozapine monitoring after the first 6 months.

  1996cited by this paper
• Clozapine eligibility among state hospital patients.

  1996cited by this paper
• Clozapine treatment for a veteran with comorbid psychosis and PTSD.

  1996cited by this paper
• Clozapine treatment for a veteran with comorbid psychosis and PTSD.

  1996cited by this paper
• Prospects for pharmacotherapy of schizophrenia.

  1995cited by this paper
• Tardive dyskinesia and substrates of energy metabolism in CSF.

  1995cited by this paper
• Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay.

  1995cited by this paper
• Parkinson's disease: drug-induced psychiatric states.

  1995cited by this paper
• Psychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Five Years

  1995cited by this paper
• Plasma Clozapine Levels and the Treatment of L-DOPA-Induced Psychosis in Parkinson's Disease

  1995cited by this paper
• Anatomical localization and regulation of somatostatin gene expression in the basal ganglia and its clinical implications.

  1995cited by this paper
• Psychopharmacology: The Fourth Generation of Progress

  1995cited by this paper
• Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease: A high potency effect of clozapine

  1995cited by this paper
• Neuroleptic-induced emesis: a new indication for clozapine?

  1995cited by this paper
• The content and context of compliance

  1995cited by this paper
• How much better is clozapine? A meta-analytic review and critical appraisal.

  1995cited by this paper
• Neuroleptic malignant syndrome associated with clozapine treatment.

  1995cited by this paper
• Clozapine decreases smoking in patients with chronic schizophrenia.

  1995cited by this paper
• D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.

  1995cited by this paper
• A medication algorithm for treatment of bipolar rapid cycling?

  1995cited by this paper
• Treatment of Polydipsia and Hyponatremia in Psychiatric Patients

  1995cited by this paper
• Effects of clozapine on smoking in chronic schizophrenic outpatients.

  1995cited by this paper
• Clozapine in tardive Tourette syndrome.

  1995cited by this paper
• Is clozapine a mood stabilizer?

  1995cited by this paper
• Reduction of comorbid substance abuse with clozapine.

  1995cited by this paper
• Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.

  1995cited by this paper
• Patient response and resource management: another view of clozapine treatment of schizophrenia.

  1995cited by this paper
• Clozapine in the treatment of a young adolescent with schizophrenia.

  1994cited by this paper
• Clozapine in tardive dyskinesia: observations from human and animal model studies.

  1994cited by this paper
• Clozapine reduces essential tremor independent of its antipsychotic effect: a case report.

  1994cited by this paper
• Clozapine treatment of spasmodic torticollis

  1994cited by this paper
• Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.

  1994cited by this paper
• Improvement of axial dystonia with the administration of clozapine.

  1994cited by this paper
• Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.

  1994cited by this paper
• Savings in hospital bed-days related to treatment with clozapine.

  1994cited by this paper
• Clozapine for polydipsia and hyponatremia in chronic schizophrenics.

  1994cited by this paper
• The use of clozapine in a mentally retarded and aggressive population.

  1994cited by this paper
• Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV.

  1994cited by this paper
• Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis.

  1994cited by this paper
• Clozapine and refractory obsessive-compulsive disorder: a case report.

  1994cited by this paper
• The prevalence of akathisia in patients receiving stable doses of clozapine.

  1994cited by this paper
• The use of clozapine in a mentally retarded and aggressive population.

  1994cited by this paper
• Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis.

  1994cited by this paper
• Predictors of response to clozapine.

  1994cited by this paper
• Treatment of delusional disorders with clozapine [3]

  1994cited by this paper
• Clozapine and refractory obsessive-compulsive disorder: a case report.

  1994cited by this paper
• Suppression of dyskinesias in advanced Parkinson's disease: Moderate daily clozapine doses provide long‐term dyskinesia reduction

  1994cited by this paper
• Clozapine in Huntington's chorea

  1994cited by this paper
• Childhood-onset schizophrenia: a followup study.

  1994cited by this paper
• Childhood-onset schizophrenia: history of the concept and recent studies.

  1994cited by this paper
• Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine.

  1994cited by this paper
• Clozapine treatment in very early onset schizophrenia.

  1994cited by this paper
• Clozapine treatment of psychosis in patients with tardive dystonia: Report of three cases

  1994cited by this paper
• Treatment of delusional disorders with clozapine.

  1994cited by this paper
• An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia.

  1994cited by this paper
• The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients.

  1994cited by this paper
• The pharmacoeconomics of clozapine: a review.

  1994cited by this paper
• Predictors of clozapine response in schizophrenia.

  1994cited by this paper
• G-CSF and the management of clozapine-induced agranulocytosis.

  1994cited by this paper
• Clozapine treatment of polydipsia.

  1994cited by this paper
• Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy.

  1994cited by this paper
• Treatment of severe axial tardive dystonia with clozapine: Case report and hypothesis

  1994cited by this paper
• Childhood-onset schizophrenia: an NIMH study in progress.

  1994cited by this paper
• Clozapine in the treatment of tremor in Parkinson's disease

  1994cited by this paper
• A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experience.

  1994cited by this paper
• Clozapine in treatment-refractory mood disorders.

  1994cited by this paper
• Lithium Monotherapy: Miracle, Myth and Misunderstanding

  1994cited by this paper
• Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome.

  1994cited by this paper
• New developments in the use of anticonvulsants as mood stabilizers.

  1993cited by this paper
• Neuroleptic medications inhibit complex I of the electron transport chain

  1993cited by this paper
• Calcium antagonists in manic-depressive illness.

  1993cited by this paper
• Clozapine and tardive dystonia.

  1993cited by this paper
• Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine.

  1993cited by this paper
• Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats.

  1993cited by this paper
• Modulatory effect of clozapine on levodopa response in parkinson's disease: A preliminary study

  1993cited by this paper
• Clozapine in the Treatment of Psychotic Refractory Depression

  1993cited by this paper
• Clozapine effects on hostility and aggression in schizophrenia.

  1993cited by this paper
• Clozapine response and adverse effects in nine brain-injured patients.

  1993cited by this paper
• Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

  1993cited by this paper

• Randomised controlled trial of clozapine in resistant schizophrenia and schizoaffective disorder

  2025cites this paper
• Metabolic effects and clinical outcomes of olanzapine in schizophrenia: A systematic review and meta-analysis

  2024cites this paper
• Clozapine for management of bipolar disorder: A case series

  2023cites this paper
• Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics

  2023cites this paper
• Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?

  2021cites this paper
• ¿Mantenimiento o retirada? Pericarditis en un paciente en tratamiento con clozapina: a propósito de un caso

  2021cites this paper
• A validated method for the simultaneous determination of quetiapine, clozapine and mirtazapine in post mortem blood and tissue samples.

  2020cites this paper
• Pharmacogénétique de la clozapine et intérêt de l’association avec la fluvoxamine

  2019cites this paper
• Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis

  2019cites this paper
• Translational Value of Drug Discrimination with Typical and Atypical Antipsychotic Drugs.

  2018cites this paper
• POUR LE DIPLOME D'ETAT DE DOCTEUR EN MEDECINE Discipline : Psychiatrie Présentée et soutenue publiquement le 19 mars 2012 A Créteil

  2012cites this paper
• Pharmacological Treatments in Schizophrenia

  2012cites this paper
• Unmet medical needs in schizophrenia treatments

  2012cites this paper
• Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action.

  2011cites this paper
• Predictors of clozapine discontinuation in patients with schizophrenia

  2011cites this paper
• The Role of Antipsychotics in Smoking and Smoking Cessation

  2011cites this paper
• Clozapine Use in Schizophrenia: Findings of the Research on Asia Psychotropic Prescription (REAP) Studies from 2001 to 2009

  2011cites this paper
• The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 mice

  2011cites this paper
• Associação entre dose diária de clozapina e níveis do fator neurotrófico derivado do cérebro em pacientes com esquizofrenia

  2011cites this paper
• Does Clozapine Promote Employability and Reduce Offending among Mentally Disordered Offenders?

  2010cites this paper
• Effet agressivolytique de la clozapine dans les pathologies neuropsychiatriques complexes

  2009cites this paper
• The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats

  2009cites this paper
• Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies

  2009cites this paper
• Clozapine-induced bowel infarction: a case report.

  2009cites this paper
• Olanzapine improves deficient sensory inhibition in DBA/2 mice.

  2008cites this paper
• Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia

  2007cites this paper
• Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia.

  2007cites this paper
• Clinical correlates of clozapine prescription for schizophrenia in China

  2007influential citation
• [Optimizing the antipsychotic potency of olanzapine by augmentation--a critical review].

  2006cites this paper
• Generalization testing with atypical and typical antipsychotic drugs in rats trained to discriminate 5.0 mg/kg clozapine from vehicle in a two‐choice drug discrimination task

  2005cites this paper
• Examen critique Augmentation of olanzapine in treatment-resistant schizophrenia

  2005cites this paper
• Augmentation of olanzapine in treatment-resistant schizophrenia.

  2005cites this paper
• Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats

  2005cites this paper
• Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital.

  2004cites this paper
• Combination of Clozapine and Amisulpride in Treatment-Resistant Schizophrenia - Case Reports and Review of the Literature

  2004cites this paper
• The Effect of Quetiapine on Cannabis Use in 8 Psychosis Patients with Drug Dependency

  2004cites this paper
• Differential effectiveness of clozapine for patients nonresponsive to or intolerant of first generation antipsychotic medications.

  2004cites this paper
• Effects of Propofol on Electroconvulsive Therapy Seizure Duration

  2004cites this paper
• Predictors of response in a sample of treatment-resistant psychotic patients on clozapine

  2004cites this paper
• Predictors of response in a sample of treatment-resistant psychotic patients on clozapine

  2004cites this paper
• Reply: Ancient Wine but Still Potent?

  2004cites this paper
• Mirtazapine for Treatment of Nausea Induced by Selective Serotonin Reuptake Inhibitors

  2004cites this paper
• Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

  2003cites this paper
• Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables.

  2002cites this paper
• Concomitant clozapine reduces smoking in patients treated with risperidone.

  2002cites this paper
• Nicotine and familial vulnerability to schizophrenia: a discordant twin study.

  2002cites this paper
• Epilepsy, psychosis and clozapine

  2002cites this paper
• Indications for the Use of Atypical Antipsychotics in the Elderly

  2001cites this paper
• Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.

  2000cites this paper
• Schizophrenia: a purinergic hypothesis.

  2000cites this paper
• An algorithm for the treatment of schizophrenia in the correctional setting: the Forensic Algorithm Project.

  2000cites this paper
• The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats

  2000cites this paper
• Clozapine: the first atypical antipsychotic

  2000cites this paper
• Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.

  2000cites this paper
• Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia.

  2000cites this paper
• Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats

  2000cites this paper
• Role of D1 and D2 dopamine receptors in the discriminative stimulus properties of the atypical antipsychotic clozapine in rats

  1999cites this paper
• Maximizing clozapine therapy: managing side effects.

  1998cites this paper
• Substance abuse in schizophrenia: a review.

  1998influential citation
• Suicide in schizophrenia: risk factors and clozapine treatment.

  1998cites this paper
• Limbic selectivity of clozapine.

  1997cites this paper
• CPA: should it carry a government health warning?

  1997cites this paper